Patent intelligence · TW
TW 202214258
Compounds and methods for treating fungal infections
Compounds and methods for treating fungal infections
Patent details — TW 202214258
- Jurisdiction
- TW
- Status
- granted
- Grant date
- Apr 16, 2022
- Expiration
- Apr 11, 2042
- Applicant
- AMPLYX PHARMACEUTICALS INC [US]
- CPC classes
- A61K 31/ 444 A I, A61K 31/ 661 A I, A61K/31444, A61K/31675
Quick answer
TW 202214258 (Compounds and methods for treating fungal infections) is held by AMPLYX PHARMACEUTICALS INC [US]. Status: granted. Granted Apr 16, 2022. Expires Apr 11, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- AMPLYX PHARMACEUTICALS INC [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 444 A I, A61K 31/ 661 A I, A61K/31444, A61K/31675, A61K/4506, A61K/90019
More from AMPLYX PHARMACEUTICALS INC [US]
Related pharmaceutical patents in our USPTO index.
-
AU 2024384453
CITRATE COORDINATION COMPLEX OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF
granted -
PT 3886798
COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF
granted -
US 20260042800
ANTIMICROBIAL PEPTIDOMIMETICS
granted -
WO 2025114603
COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT D'INFECTIONS FONGIQUES
granted -
WO 2024094329
PRÉPARATION DE CAPSULE SOUS EMBALLAGE COQUE CONTENANT DU SULFATE D'ISAVUCONAZONIUM
granted -
CA 3268414
MÉTHODES DE TRAITEMENT D'INFECTIONS AVEC BACTÉRIÉMIE À STAPHYLOCOCCUS AUREUS
granted -
AU 2022323463
ANTIMICROBIAL PEPTIDOMIMETICS
granted -
AR 127448
DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER
granted
Frequently asked questions
What is US patent 202214258?
TW 202214258 (Compounds and methods for treating fungal infections) is held by AMPLYX PHARMACEUTICALS INC [US]. Status: granted. Granted Apr 16, 2022. Expires Apr 11, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns TW 202214258?
AMPLYX PHARMACEUTICALS INC [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does TW 202214258 expire?
Our index shows an expiration date of Apr 11, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.